IMPORTANT SAFETY INFORMATION: STIVARGA can cause liver problems, which can be serious and sometimes lead to death. Your healthcare provider will do blood tests... Continue reading below
Bayer, the Bayer Cross, STIVARGA® (regorafenib), and REACH® are registered trademarks of Bayer.

Helping you get and pay for your medicine

$0 Co-Pay program*
REACH patient program
Access to STIVARGA

Reach out for help with patient access or support services

When you are living with your disease, your focus should be your health

That‘s why patients taking STIVARGA can enroll in REACH® (Resources for Expert Assistance and Care Helpline). This free program is here to support you and your caregivers with information about therapy and financial assistance options.

The REACH program offers:

Nurse Counselors Nurse
Counselors
Nurse counselors to answer your medical questions and provide educational and support materials, as well as guidance on side effects
STIVARGA (regorafenib)  Financial Access Counselors Financial Access
Counselors
Financial access counselors to provide help with benefits
  • Benefit verification and specialty pharmacy provider (SPP) identification
  • Patient Assistance Program (PAP) for the uninsured or underinsured
  • Prior authorizations and denial/appeal information
  • Co-pay assistance for eligible commercially insured patients not previously enrolled in the REACH Commercial Co-Pay Assistance Program*
  • Alternative coverage research
    • Referral to independent organizations that may assist eligible patients with their out-of-pocket expenses

Call 1-866-639-2827 or speak to your doctor to REACH your support benefits today.

*Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payors of any benefits they receive and the value of this program, and may not participate if this program is prohibited by or conflicts with their private insurance policy, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in Bayer’s Patient Assistance Program are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product and modify or discontinue any aspect of the REACH program at any time, including but not limited to this commercial co-pay assistance program.
Patients who do or do not meet the requirements for REACH do not automatically qualify for financial help from charitable organizations.

Indications

STIVARGA (regorafenib) is a prescription medicine used to treat people with:

It is not known if STIVARGA is safe and effective in children less than 18 years of age.

Important Safety Information

STIVARGA (regorafenib) can cause liver problems, which can be serious and sometimes lead to death. Your healthcare provider will do blood tests to check your liver function before you start taking STIVARGA and during your treatment with STIVARGA to check for liver problems. Tell your healthcare provider right away if you experience yellowing of your skin or the white part of your eyes, nausea, vomiting, dark urine, or change in your sleep pattern.

Before taking STIVARGA, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the prescription and over-the-counter medicines, vitamins, and herbal supplements you take. Avoid drinking grapefruit juice and taking St. John’s Wort while taking STIVARGA.

STIVARGA may cause serious side effects, including:

The most common side effects with STIVARGA include pain including stomach-area (abdomen); tiredness, weakness, fatigue; diarrhea (frequent or loose bowel movements); decreased appetite; infection; voice change or hoarseness; increase in certain liver function tests; fever; swelling, pain, and redness of the lining in your mouth, throat, stomach, and bowel (mucositis); and weight loss.

For important risk and use information about STIVARGA, please see the full Prescribing Information, including Boxed Warning.

You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.